-
Mashup Score: 215Cracking the sparkle code - 7 day(s) ago
Christina Termini, a cancer cell biologist who joined Fred Hutch Cancer Center in 2022, has won a $600,000, three-year award from the V Foundation for Cancer Research to study how protein sugaring affects treatment for the deadliest blood cancer, acute myeloid leukemia.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4Polygenic risk scores and prostate cancer - 8 day(s) ago
Research by Fred Hutch Cancer Center genetic epidemiologist Burcu Darst, PhD, and scientists from the Canary Prostate Active Surveillance Study (PASS), suggests that a patient’s polygenic risk score, or PRS, may be able to help clinicians differentiate the more dangerous prostate cancers from those that will never cause an issue.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Polygenic risk scores may be able to help clinicians differentiate the more dangerous prostate cancers from those that will never cause an issue, according to research by Fred Hutch and scientists from the Canary Prostate Active Surveillance Study. https://t.co/MNtVBkCij8
-
-
Mashup Score: 3Polygenic risk scores and prostate cancer - 10 day(s) ago
Research by Fred Hutch Cancer Center genetic epidemiologist Burcu Darst, PhD, and scientists from the Canary Prostate Active Surveillance Study (PASS), suggests that a patient’s polygenic risk score, or PRS, may be able to help clinicians differentiate the more dangerous prostate cancers from those that will never cause an issue.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Polygenic risk scores may be able to help clinicians differentiate the more dangerous prostate cancers from those that will never cause an issue, according to research by Fred Hutch and scientists from the Canary Prostate Active Surveillance Study. https://t.co/MNtVBkCij8
-
-
Mashup Score: 7Fred Hutch research shines at national oncology conference - 10 day(s) ago
Fred Hutch Cancer Center researchers shared their latest findings at the annual meeting of the Society for Immunotherapy of Cancer (SITC), held in Houston from November 6-10.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch researchers shared new research at the @sitcancer meeting in early Nov. Findings included new strategies to avoid T-cell exhaustion in CAR T cells & insights into how solid tumors change microenvironment to blunt the immune system’s response. https://t.co/GNf8WOzd05
-
-
Mashup Score: 0Infectious Diseases in the Immunocompromised Host Symposium - 11 day(s) ago
The 5th Symposium on Infectious Diseases in the Immunocompromised Host will bring together leaders and trainees in research and clinical care of infectious diseases in the immunocompromised host.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Registration for the 5th Symposium on Infectious Diseases in the Immunocompromised Host is now open! This symposium brings together leaders and trainees in research and clinical care of #infectiousdiseases in the #immunocompromised host. Learn more: https://t.co/8p0qm3Hx27
-
-
Mashup Score: 203Cracking the sparkle code - 12 day(s) ago
Christina Termini, a cancer cell biologist who joined Fred Hutch Cancer Center in 2022, has won a $600,000, three-year award from the V Foundation for Cancer Research to study how protein sugaring affects treatment for the deadliest blood cancer, acute myeloid leukemia.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch cancer cell biologist @CterminiPhD won a $600K grant from @TheVFoundation to study how protein modifications impact acute myeloid leukemia (#AML) treatment — work that could unlock new insights into #bloodcancer therapies. https://t.co/txyQcXjLU9
-
-
Mashup Score: 15Multi-center study shows education level, income impact access to stem cell transplantation for acute myeloid leukemia patients - 13 day(s) ago
SAN DIEGO, Calif. — Dec. 8, 2024 — Patients with acute myeloid leukemia who have lower education and income are less likely to receive a allogeneic hematopoietic stem cell transplant for acute myeloid, however, if they can access the treatment, are equally likely to benefit from transplant as patients with more education and higher income, according to a new study from Fred Hutch Cancer Center presented today at the annual meeting of the American Society of Hematology. The study, which analyzed zip
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch at #ASH24: Drs. Natalie Wuliji and @msorror discuss a multi-center study showing how social determinants of health affect access to allogeneic transplant for adults with #AML. Learn more: https://t.co/MDeGo427YY https://t.co/URqyBlVc0f
-
-
Mashup Score: 21Fred Hutch PhD student honored by American Society of Hematology - 13 day(s) ago
Rasika Venkataraman, a third-year doctoral student working in the lab of Stanley C. Lee, PhD, at Fred Hutch Cancer Center, has been honored with the 2024 ASH Graduate Hematology Award for her research on genetic predisposition linked to the gene DDX41 and its connection to hematological diseases.
Source: www.fredhutch.orgCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch PhD student @rasikavnkt of the @StanleyCLee Lab has been honored with the 2024 @ASH_hematology Graduate Hematology Award for her research on genetic predisposition linked to the gene DDX41 and its connection to hematological diseases. #ASH24 https://t.co/MzdZXHhBmB
-
-
Mashup Score: 3Paper: Donor XCR1+ and CD11b+ Dendritic Cells Determine the Severity of Th1 and Th17-Dependent Acute Gvhd within the Gastrointestinal Tract - 14 day(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 701. Experimental Transplantation: Basic and Translational: GVHD, GVL and Alloimmunity Hematology Disease Topics & Pathways: Research, Translational Research Motoko Koyama, MD, PhD 1, Shuichiro Takahashi, MD, PhD 2,3 *, Takayuki Inoue, MD, PhD 3,4 *, Kathleen S Ensbey 3 *, Samuel R. W. Legg 3 *, Tomoko Sekiguchi 3 *, Ethan Nelson 3 *, Nicole S Nemychenkov 3 *, Tanvi Joshi 3 *, Simone A Minnie, PhD 1, Albert C Yeh, MD 3,5, Julie R Boiko, MD, MS 3,5,
Source: ash.confex.comCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch at #ASH24: Catch Dr. Motoko Koyama's presentation: "Donor XCR1+ and CD11b+ Dendritic Cells Determine the Severity of Th1 and Th17-Dependent Acute Gvhd within the Gastrointestinal Tract" 👉 https://t.co/akYSWlDb6G https://t.co/9hYNHatfgm
-
-
Mashup Score: 1
Program: Oral and Poster Abstracts Type: Oral Session: 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Risk Adapted Approaches to Reduce Transplant Related Toxicities Hematology Disease Topics & Pathways: Research, AML, Acute Myeloid Malignancies, Adult, Elderly, Epidemiology, Clinical Research, Patient-reported outcomes, Diseases, Treatment Considerations, Adverse Events, Myeloid Malignancies, Human, Study Population 1 Clinical Research Division, Fred Hutchinson
Source: ash.confex.comCategories: General Medicine News, Oncologists1Tweet-
Fred Hutch at #ASH24: Catch @msorror present the latest findings on a new health assessment model called CHARM, which helps health care teams predict which patients will survive transplantation. 👉 https://t.co/Y2SAimreo7 https://t.co/UEJ7aTzMtM
-
Fred Hutch cancer cell biologist @CterminiPhD won a $600K grant from @TheVFoundation to study how protein modifications impact acute myeloid leukemia (#AML) treatment — work that could unlock new insights into #bloodcancer therapies. https://t.co/txyQcXjLU9